Amdocs Sees Q4 EPS $1.67-$1.73 Vs $1.71 Est.; Revenue $1.24B-$1.28B Vs $1.27B Est.; Revises FY24 EPS Growth Guidance Range From 7%-11% To 8.5%-9.5%; Revises FY24 Revenue Growth Guidance Range From 1.6%-3.6% To 1.9%-2.7%
Portfolio Pulse from Benzinga Newsdesk
Amdocs has provided its Q4 and FY24 financial outlook, with Q4 EPS expected to be between $1.67 and $1.73, slightly above the $1.71 estimate. Revenue for Q4 is projected to be between $1.24 billion and $1.28 billion, close to the $1.27 billion estimate. The company has revised its FY24 EPS growth guidance to 8.5%-9.5% from 7%-11% and its revenue growth guidance to 1.9%-2.7% from 1.6%-3.6%.
August 07, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amdocs has updated its Q4 and FY24 financial outlook, with Q4 EPS expected to be between $1.67 and $1.73, slightly above the $1.71 estimate. Revenue for Q4 is projected to be between $1.24 billion and $1.28 billion, close to the $1.27 billion estimate. The company has also revised its FY24 EPS growth guidance to 8.5%-9.5% from 7%-11% and its revenue growth guidance to 1.9%-2.7% from 1.6%-3.6%.
The updated guidance for Q4 and FY24 shows slight improvements in EPS and revenue estimates, which is likely to have a positive short-term impact on Amdocs' stock price. The revisions indicate better-than-expected performance, which should be well-received by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100